Clinical Trial Update: Drosophila-generated CTL [Phase 2]

View source ↗

Summary

Phase 2 trial update from the National Cancer Institute on Drosophila-generated cytotoxic T lymphocytes for metastatic cutaneous melanoma. The study was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Cutaneous Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2012-12-13